Guangdong Taienkang Pharmaceutical Co., Ltd.

XSEC:301263 Stock Report

Market Cap: CN¥6.1b

Guangdong Taienkang Pharmaceutical Balance Sheet Health

Financial Health criteria checks 4/6

Guangdong Taienkang Pharmaceutical has a total shareholder equity of CN¥1.8B and total debt of CN¥255.9M, which brings its debt-to-equity ratio to 14%. Its total assets and total liabilities are CN¥2.3B and CN¥461.1M respectively. Guangdong Taienkang Pharmaceutical's EBIT is CN¥158.8M making its interest coverage ratio -44.2. It has cash and short-term investments of CN¥589.4M.

Key information

14.0%

Debt to equity ratio

CN¥255.86m

Debt

Interest coverage ratio-44.2x
CashCN¥589.40m
EquityCN¥1.82b
Total liabilitiesCN¥461.08m
Total assetsCN¥2.29b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 301263's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥340.7M).

Long Term Liabilities: 301263's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥120.4M).


Debt to Equity History and Analysis

Debt Level: 301263 has more cash than its total debt.

Reducing Debt: 301263's debt to equity ratio has increased from 6.4% to 14% over the past 5 years.

Debt Coverage: 301263's debt is not well covered by operating cash flow (10.9%).

Interest Coverage: 301263 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies